专题论文

定量蛋白质组学及其在颅内动脉瘤中的研究进展

  • 王佳 ,
  • 赵继宗
展开
  • 1. 首都医科大学附属北京天坛医院国家神经系统疾病临床医学研究中心, 北京 100050;
    2. 首都医科大学附属北京天坛医院神经外科, 北京 100050
王佳,博士研究生,研究方向为脑血管疾病,电子信箱:wangjia1118@hotmail.com

收稿日期: 2016-12-02

  修回日期: 2017-01-20

  网络出版日期: 2017-02-28

基金资助

国家科技支撑计划项目(2015BAI12B04);北京市医院管理局“使命”计划项目(SML20150501)

Comparative proteome analysis of intracranial aneurysms

  • WANG Jia ,
  • ZHAO Jizong
Expand
  • 1. China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China;
    2. Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China

Received date: 2016-12-02

  Revised date: 2017-01-20

  Online published: 2017-02-28

摘要

颅内动脉瘤(IA)是颅内动脉壁的某一部分因病变而向外突出所形成的永久性扩张,是造成蛛网膜下腔出血的首位病因。定量蛋白质组学,作为新近出现的一种崭新的研究手段,为治疗颅内动脉瘤提供了新的研究思路。通过同位素标记相对和绝对定量(iTRAQ)技术及二维液相色谱-串联质谱(2D-LC-MS/MS)法筛选动脉瘤壁差异表达蛋白质,为动脉瘤形成和破裂的分子机制研究提供了帮助。本文综述了颅内动脉瘤的研究进展以及定量蛋白质组学技术在颅内动脉瘤研究中的应用。

本文引用格式

王佳 , 赵继宗 . 定量蛋白质组学及其在颅内动脉瘤中的研究进展[J]. 科技导报, 2017 , 35(4) : 60 -63 . DOI: 10.3981/j.issn.1000-7857.2017.04.010

Abstract

The intracranial aneurysm (IA) is a cerebrovascular disorder in which the weakness in the wall of a cerebral artery or vein causes a localized dilation or ballooning of the blood vessel. The quantitative proteomics is to obtain quantitative information about all proteins in a sample. The quantitative proteomics is mainly performed by isobaric tagging for relative and absolute quantitation (iTRAQ) and 2-DE or mass spectrometry (MS). The identification of the proteins related to the intracranial aneurysm (IA) wall biological activities could help to find novel pathological mechanisms and therapeutic targets for the human intracranial aneurysm. This paper reviews the applications of quantitative proteomics technology in the study of intracranial aneurysm.

参考文献

[1] Arimura H, Li Q, Korogi Y, et al. Computerized detection of intracrani-al aneurysms for three-dimensional MR angiography:Feature extrac-tion of small protrusions based on a shape-based difference image tech-nique[J]. Medical Physics, 2006, 33(2):394-401.
[2] Gasparotti R, Liserre R. Intracranial aneurysms[J]. European Radiology, 2005, 15(3):441-447.
[3] 陈轶, 孙清荣, 廖翠薇, 等. CTA减影法在颅内动脉瘤检查中的应用价值[J]. 第三军医大学学报, 2007, 29(22):2197-2198. Chen Yi, Sun Qingrong, Liao Cuiwei, et al. The value of CTA subtrac-tion in the examination of intracranial aneurysms[J]. Acta Academiae Medicinae Militaris Tertiae, 2007, 29(22):2197-2198.
[4] Yu U S, Lee S H, Kim Y J, et al. Bioinformatics in the post-genome era[J]. BMB Reports, 2004, 37(1):75-82.
[5] Wang T, Cui Y, Jin J, et al. Translating mRNAs strongly correlate to proteins in a multivariate manner and their translation ratios are pheno-type specific[J]. Nucleic Acids Research, 2013, 41(9):4743-54.
[6] Wang J, Mei H, Zheng C, et al. The metabolic regulation of sporulation and parasporal crystal formation in Bacillus thuringiensis revealed by transcriptomics and proteomics[J]. Molecular & Cellular Proteomics, 2013, 12(5):1363-1376.
[7] Zeng J, Liu Y, Liu W, et al. Integration of transcriptome, proteome and metabolism data reveals the alkaloids biosynthesis in Macleaya cordata and Macleaya microcarpa[J]. PLoS One, 2013, 8(1):e53409.
[8] Stelzl U, Worm U, Lalowski M, et al. A human protein-protein interac-tion network:A resource for annotating the proteome[J]. Cell, 2005, 122(6):957-968.
[9] Aebersold R, Mann M. Mass spectrometry-based proteomics[J]. Nature, 2003, 422(6928):198-207.
[10] Cravatt B F, Simon G M, Yate J R.The biological impact of massspectrometry based proteomics[J]. Nature, 2007, 450(7172):991-1000.
[11] Domon B, Aebersold R. Mass spectrometry and protein analysis[J]. Sci-ence, 2006, 312(5771):212-217.
[12] Sun C Y, Xia G W, Xu K, et al. Application of iTRAQ in proteomic study of prostate cancer[J]. National Journal of Andrology, 2010, 16(8):741.
[13] 李伟. iTRAQ多重化学标记串联质谱技术在比较蛋白质组学中的应用[J]. 生命的化学, 2006, 26(5):453-456. Li Wei. Application of iTRAQ-MS/MS in comparative proteomics[J]. Chemistry of Life, 2006,26(5):452-456.
[14] Kurki M I, Häkkinen S K, Frösen J, et al. Upregulated signaling path-ways in ruptured human saccular intracranial aneurysm wall:an emerging regulative role of Toll-like receptor signaling and nuclear factor-κB, hypoxia-inducible factor-1A, and ETS transcription factors.[J]. Neurosurgery, 2011, 68(6):1675-1676.
[15] Modrego J, López-Farré A J, Martínez-López I, et al. Expression of cy-toskeleton and energetic metabolism-related proteins at human abdom-inal aortic aneurysm sites[J]. Journal of Vascular Surgery, 2012, 55(4):1124-1133.
[16] 谢秀枝, 王欣, 刘丽华, 等. iTRAQ技术及其在蛋白质组学中的应用[J]. 中国生物化学与分子生物学报, 2011, 27(7):616-621. Xie Xiuzhi, Wang Xin, Liu Lihua, et al. ITRAQ technology and its ap-plication in proteomics[J]. Chinese Journal of Biochemistry and Molec-ular Biology, 2011, 27(7):616-621.
[17] Wang J, Yu L, Huang X, et al. Comparative proteome analysis of sac-cular intracranial aneurysms with iTRAQ quantitative proteomics[J]. Journal of Proteomics, 2016, 130:120-128.
[18] 王道奎, 王成东, 曲秉坤, 等. 颅内动脉瘤壁的定量蛋白质组学研究[J]. 中华神经外科杂志, 2013, 29(12):1281-1285. Wang Daokui, Wang Chengdong, Qu Bingkun, et al. Quantitative pro-teomic analysis of the intracranial aneurysm wall using iTRAQ label-ing coupled with 2D LC-MS/MS[J]. Chinese Journal of Neurosurgery, 2013, 29(12):1281-1285.
[19] 周杰. 颅内动脉瘤患者血清差异蛋白质谱表达模型研究[D]. 泸州:泸州医学院, 2009. Zhou Jie. A study of serum differential protein mass spectra expres-sion model of patients with intracranial aneurysms[D]. Luzhou:Luzhou Medical College, 2009.
[20] Maurer M H, Haux D, Sakowitz O W, et al. Identification of early markers for symptomatic vasospasm in human cerebral microdialysate after subarachnoid hemorrhage:Preliminary results of a proteomewide screening[J]. Journal of Cerebral Blood Flow & Metabolism, 2007, 27(10):1675-1683
文章导航

/